Renin-Angiotensin System Blockers May Prolong Survival of Metastatic Non-Small Cell Lung Cancer Patients Receiving Erlotinib

The aim of this study is to determine whether renin-angiotensin system blockers (RASBs), which include angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-2 receptor 1 blockers (ARBs), improve the overall survival (OS) of patients with metastatic non-small cell lung cancer (NSCLC). The...

Descripción completa

Detalles Bibliográficos
Autores principales: Aydiner, Adnan, Ciftci, Rumeysa, Sen, Fatma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616356/
https://www.ncbi.nlm.nih.gov/pubmed/26039117
http://dx.doi.org/10.1097/MD.0000000000000887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616356/
https://www.ncbi.nlm.nih.gov/pubmed/26039117
http://dx.doi.org/10.1097/MD.0000000000000887

Ejemplares similares